Jaime Xinos
Corporate Officer/Principal chez ACHIEVE LIFE SCIENCES, INC.
Profil
Jaime Xinos is currently the Executive Vice President-Commercial at Achieve Life Sciences, Inc. Prior to this, she worked as the Senior Director-Global Oncology Commercial at OncoGenex Pharmaceuticals, Inc. from 2010 to 2017.
Ms. Xinos has an undergraduate degree and an MBA from the University of Illinois.
Postes actifs de Jaime Xinos
| Sociétés | Poste | Début |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Corporate Officer/Principal | 01/01/2017 |
Anciens postes connus de Jaime Xinos
| Sociétés | Poste | Fin |
|---|---|---|
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Public Communications Contact | 01/01/2010 |
Formation de Jaime Xinos
| University of Illinois | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
